Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7233)
All Articles published online
|
Publishing Process of This Article
|
Feb 21, 2015 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tan YW, Ye Y, Ge GH, Zhao W, Gan JH, Zhao Y, Niu ZL, Zhang DJ, Chen L, Yu XJ, Yang LJ. Natural YMDD-motif mutants affect clinical course of lamivudine in chronic hepatitis B. World J Gastroenterol 2015; 21(7): 2089-2095 [PMID: 25717242 DOI: 10.3748/wjg.v21.i7.2089] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i7/2089.htm |
| Number | Citing Articles |
| 1 |
Xiaoguang Wang, Xiaodan Yang, Fei Chen, Shaohan Wu, Zhengwei Song, Jianguo Fei, Giovanni Marasco. Hepatitis B Virus Reactivation Potential Risk Factors in Hepatocellular Carcinoma via Transcatheter Arterial Chemoembolization: A Retrospective Research. Canadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/8864655
|
| 2 |
Claudia Bozza, Marika Cinausero, Donatella Iacono, Fabio Puglisi. Hepatitis B and cancer: A practical guide for the oncologist. Critical Reviews in Oncology/Hematology 2016; 98: 137 doi: 10.1016/j.critrevonc.2015.10.017
|
| 3 |
Hongcan Liu, Zemin Wan, Lanhui She, Yajuan Zhu, Zhiliang Cai, Bin Wu, Qizhen Zhuang, Peifeng Ke, Xinzhong Wu, Zhuo Li, Xianzhang Huang. Inflammation Pharmacological Reaction and YMDD Mutational Patterns in Lamivudine Therapeutics Hepatitis B Virus. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.648170
|
| 4 |
S. Wang, H. Li, Z. Kou, F. Ren, Y. Jin, L. Yang, X. Dong, M. Yang, J. Zhao, H. Liu, N. Dong, L. Jia, X. Chen, Y. Zhou, S. Qiu, R. Hao, H. Song. Highly sensitive and specific detection of hepatitis B virus DNA and drug resistance mutations utilizing the PCR-based CRISPR-Cas13a system. Clinical Microbiology and Infection 2021; 27(3): 443 doi: 10.1016/j.cmi.2020.04.018
|
| 5 |
Qiaoqiao Zhu, Nannan Xu, Ying Xu, Yingying Dong, Ning Xu. Label-free surface-enhanced Raman spectroscopy detection for tyrosine-methionine-aspartate-aspartate (YMDD)-motif mutants of HBV DNA. Vibrational Spectroscopy 2021; 114: 103253 doi: 10.1016/j.vibspec.2021.103253
|
| 6 |
Aylin Calica Utku, Oguz Karabay. Treatment of chronic hepatitis B patients with tyrosine-methionine-aspartate-aspartate mutations. World Journal of Gastroenterology 2016; 22(4): 1727-1728 doi: 10.3748/wjg.v22.i4.1727
|
| 7 |
|